Bank of Montreal Cuts McKesson Stock Position by 24%

The Canadian bank reduced its stake in the pharmaceutical distributor during the third quarter.

Mar. 11, 2026 at 7:20am

Bank of Montreal Can cut its position in McKesson Corporation (NYSE:MCK) by 24.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 297,051 shares of the company's stock after selling 94,763 shares during the quarter, valued at approximately $229,484,000.

Why it matters

This filing provides insight into the investment strategy of a major institutional investor, Bank of Montreal Can, and its view on the prospects of pharmaceutical distributor McKesson Corporation. The reduced stake could signal concerns about the company's outlook or a reallocation of the bank's portfolio.

The details

According to the 13F filing, Bank of Montreal Can sold 94,763 shares of McKesson stock during the third quarter, reducing its total position to 297,051 shares. This represented approximately 0.24% of McKesson's outstanding shares at the end of the reporting period.

  • Bank of Montreal Can filed the 13F report disclosing the reduced McKesson position on March 11, 2026.
  • The filing covers the third quarter of 2025.

The players

Bank of Montreal Can

A major Canadian financial institution and investment management firm.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduced stake by Bank of Montreal Can in McKesson could signal broader concerns about the pharmaceutical distribution industry or the company's specific outlook. Investors will likely watch for any further changes in major institutional holdings of McKesson stock.